BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 26, 2026
See today's BioWorld
Home
» Karo Bio raising $13M as it steps back to preclinical research
To read the full story,
subscribe
or
sign in
.
Karo Bio raising $13M as it steps back to preclinical research
Feb. 14, 2014
By
Cormac Sheridan
Shares in Karo Bio AB dropped 13 percent Thursday on news that the company was raising SEK84.7 million (US$13.1 million) in a heavily discounted share issue.
BioWorld
